CN102940839A - Traditional Chinese medicine composition for treating chronic atrophic gastritis - Google Patents
Traditional Chinese medicine composition for treating chronic atrophic gastritis Download PDFInfo
- Publication number
- CN102940839A CN102940839A CN2012103472876A CN201210347287A CN102940839A CN 102940839 A CN102940839 A CN 102940839A CN 2012103472876 A CN2012103472876 A CN 2012103472876A CN 201210347287 A CN201210347287 A CN 201210347287A CN 102940839 A CN102940839 A CN 102940839A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- atrophic gastritis
- chronic atrophic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 239000002994 raw material Substances 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 241001522129 Pinellia Species 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 9
- 210000001156 gastric mucosa Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010054949 Metaplasia Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000015689 metaplastic ossification Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 208000004300 Atrophic Gastritis Diseases 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000036495 Gastritis atrophic Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- ZQUAVILLCXTKTF-UHFFFAOYSA-H bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[K+].[K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZQUAVILLCXTKTF-UHFFFAOYSA-H 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
- 229960001253 domperidone Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis. The medicine is composed of the following Chinese medicinal materials, by weight: 10-40 parts of Fructus Trichosanthis, 5-20 parts of Rhizoma Pinelliae, 3-15 parts of Rhizoma Coptidis, 5-25 parts of Fructus Aurantii Immaturus, 5-20 parts of Poria cocos, 5-25 parts of bighead atractylodes rhizome, 5-20 parts of szechwan Chinaberry fruit, 3-15 parts of Radix Aucklandiae, 5-25 parts of the root of red-rooted salvia, 3-15 parts of Fructus Amomi, 5-20 parts of Angelica sinensis, 5-20 parts of raw pollen typhae, and 3-10 parts of liquorice. The traditional Chinese medicine composition provided by the invention has effects of tonifying spleen, appetizing, tretching liver to smooth qi, resolving dampness, dredging stasis, clearing heat, nourishing yin, promoting blood circulation and dispersing blood stasis, and has advantages of obvious curative effect on chronic atrophic gastritis, reliable function, wide medicinal source, simple preparation, and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicinal preparation of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis.
Background technology
A kind of common digestive system disease of chronic atrophic gastritis take the atrophy of gastric mucosa body of gland as feature is the digestive system common disease.It is reported: in China, the chronic atrophic gastritis sickness rate accounts for the crowd's of being examined 13.8%.Clinical manifestation be abdominal distention, upper abdominal pain or epigastric discomfort, early full sense, a little polyphagia then abdominal distention is more obvious, even belch occurs, feel sick, dyspepsia, tired, become thin, poor appetite, the symptoms such as anemia, Most patients can have epigastrium causalgia, distending pain, dull pain or distension, painful abdominal mass vexed, especially with after eating for very, the symptoms such as inappetence, nauseating, belch, constipation or diarrhoea.Pathogenic factor has a lot, all damages easily the barrier function of gastric mucosa such as hobby of arteriosclerosis, stomach Insufficience of blood flow, cigarette,wine and tea etc. and causes chronic atrophic gastritis.Show that according to epidemiology the incidence rate of Chronic Atrophic Gastritis Patients gastric cancer is apparently higher than the general population.The treatment chronic atrophic gastritis is to stop chronic atrophic gastritis to develop to reduce the effective means of gastric cancer incidence rate to gastric cancer.Modern medicine still lacks desirable Therapeutic Method, can only carry out symptomatic treatment and the treatment of protection gastric mucosa.For example the upper abdomen distending pain can take the Chinese medicine preparation that the spleen invigorating such as SANJIU WEITAI are regulated the flow of vital energy; Abdeminal pain, feel sick, belch can use cisapride, motilium etc.; Such as gastric mucosa course inflammatory activity is arranged, helicobacter pylori is positive, can take the preparation of bismuth-containing such as tripotassium dicitratobismuthate etc.The Chinese medicine of A, E, C, vitamin B group and QI invigorating nourishing the stomach recovers favourable to gastric mucosa.But there is the undesirable deficiency of curative effect.
Chronic atrophic gastritis is equivalent to the categories such as motherland's medical science " gastric abscess ", and its sick position is at stomach.In recent years, extensive and fruitful research has also been carried out in the aspect such as dialectical, the rule for the treatment of side's medicine of the diagnosis of traditional Chinese medical science bound pair chronic atrophic gastritis, infrastest.
The traditional Chinese medical science thinks, primary disease is many because of due to the factors such as the cold-evil stagnates, diet damage, feelings will are unsuccessful, at a slow speed infection, medicine and heredity.Stomach is positive internal organs, the many blood of many gas, with logical reduce to suitable, preferring moisture to dryness if the cold-evil stagnates, eating and drinking without temperance, feelings will are unsuccessful, infection, medicine etc., all can damage the stomach internal organs, cause stomach-QI being unable to descend normally, the stagnation of QI is not all right, and metabolite is constantly put aside, burnt among the Yu Yu, strongly fragrant heat-transformation of a specified duration, pathogen usually intruding into collateral in protracted disease, cloudy blood consumption is hindered, weakness of the spleen and stomach, QI and blood is deficient, and the deficiency of vital energy then is difficult promoting the circulation of blood.
For the pathogeny of chronic atrophic gastritis, take benefiting qi and removing blood stasis as the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome prior art Chinese patent medicine and the doctor trained in Western medicine deficiency undesirable to the chronic atrophic gastritis therapeutic effect, the invention provides a kind ofly prepare conveniently, the medicine source is wide, cost is low, the Chinese medicine composition of evident in efficacy, reliable effect, the treatment chronic atrophic gastritis that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10～40 parts of Fructus Trichosanthis, 5～20 parts of the Rhizoma Pinelliaes, 3～15 parts of Rhizoma Coptidis, 5～25 parts of Fructus Aurantii Immaturuss, 5～20 parts in Poria, 5～25 parts of the Rhizoma Atractylodis Macrocephalaes, 5～20 parts of Fructus Toosendans, 3～15 parts of the Radix Aucklandiae, 5～25 parts of Radix Salviae Miltiorrhizaes, 3～15 parts of Fructus Amomis, 5～20 parts of Radix Angelicae Sinensis, 5～20 parts of Pollen Tyjphae, 3～10 parts in Radix Glycyrrhizae.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 30 parts of Fructus Trichosanthis, 12 parts of the Rhizoma Pinelliaes, 6 parts of Rhizoma Coptidis, 15 parts of Fructus Aurantii Immaturuss, 10 parts in Poria, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Toosendans, 6 parts of the Radix Aucklandiae, 15 parts of Radix Salviae Miltiorrhizaes, 6 parts of Fructus Amomis, 10 parts of Radix Angelicae Sinensis, 10 parts of Pollen Tyjphae, 6 parts in Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Fructus Trichosanthis has clearing away heat and eliminating phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, moisturizes the effect of laxation; The Rhizoma Pinelliae has drying dampness to eliminate phlegm, the effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Rhizoma Coptidis has the effect of heat clearing and damp drying, eliminating fire and detoxication; Fructus Aurantii Immaturus has the effect of the loose painful abdominal mass of reducing phlegm, dispelling the stagnated QI removing food stagnancy; Poria has the effect of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming; The Rhizoma Atractylodis Macrocephalae has the effect of invigorating the spleen and benefiting QI, dampness diuretic; Fructus Toosendan have soothing the liverly expel the heat-evil, the effect of promoting the circulation of QI to relieve pain, parasite killing; The Radix Aucklandiae has the effect of intestinal stasis relieving in promoting the circulation of QI to relieve pain, the accent; Radix Salviae Miltiorrhizae has the effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, the effect of loosening bowel to relieve constipation; Pollen Tyjphae has hemostasis, blood stasis dispelling, treating stranguria effect; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.Drug component in the present composition is through dialectical compatibility, complement each other using, have synergism, play altogether the effect of spleen benefiting and stimulating the appetite, depressed liver-energy dispersing and QI regulating, removing dampness intestinal stasis relieving, clearing away heat and nourishing YIN, blood circulation promoting and blood stasis dispelling, chronic atrophic gastritis is reached the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, total effective rate 93.7%, cure rate reaches 62.5%.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, its raw material of Chinese medicine by following weight proportion forms: Fructus Trichosanthis 30g, Rhizoma Pinelliae 12g, Rhizoma Coptidis 6g, Fructus Aurantii Immaturus 15g, Poria 10g, Rhizoma Atractylodis Macrocephalae 15g, Fructus Toosendan 10g, Radix Aucklandiae 6g, Radix Salviae Miltiorrhizae 15g, Fructus Amomi 6g, Radix Angelicae Sinensis 10g, Pollen Tyjphae 10g, Radix Glycyrrhizae 6g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, its raw material of Chinese medicine by following weight proportion forms: Fructus Trichosanthis 40g, Rhizoma Pinelliae 10g, Rhizoma Coptidis 3g, Fructus Aurantii Immaturus 20g, Poria 15g, Rhizoma Atractylodis Macrocephalae 5g, Fructus Toosendan 12g, Radix Aucklandiae 15g, Radix Salviae Miltiorrhizae 5g, Fructus Amomi 10g, Radix Angelicae Sinensis 20g, Pollen Tyjphae 8g, Radix Glycyrrhizae 10g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, its raw material of Chinese medicine by following weight proportion forms: Fructus Trichosanthis 20g, Rhizoma Pinelliae 15g, Rhizoma Coptidis 5g, Fructus Aurantii Immaturus 25g, Poria 5g, Rhizoma Atractylodis Macrocephalae 10g, Fructus Toosendan 20g, Radix Aucklandiae 3g, Radix Salviae Miltiorrhizae 10g, Fructus Amomi 15g, Radix Angelicae Sinensis 15g, Pollen Tyjphae 5g, Radix Glycyrrhizae 8g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, its raw material of Chinese medicine by following weight proportion forms: Fructus Trichosanthis 10g, Rhizoma Pinelliae 20g, Rhizoma Coptidis 15g, Fructus Aurantii Immaturus 5g, Poria 20g, Rhizoma Atractylodis Macrocephalae 25g, Fructus Toosendan 5g, Radix Aucklandiae 10g, Radix Salviae Miltiorrhizae 20g, Fructus Amomi 3g, Radix Angelicae Sinensis 8g, Pollen Tyjphae 12g, Radix Glycyrrhizae 5g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, its raw material of Chinese medicine by following weight proportion forms: Fructus Trichosanthis 25g, Rhizoma Pinelliae 5g, Rhizoma Coptidis 10g, Fructus Aurantii Immaturus 10g, Poria 12g, Rhizoma Atractylodis Macrocephalae 20g, Fructus Toosendan 15g, Radix Aucklandiae 12g, Radix Salviae Miltiorrhizae 25g, Fructus Amomi 8g, Radix Angelicae Sinensis 5g, Pollen Tyjphae 20g, Radix Glycyrrhizae 3g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 8 centimetres of powder, carry out decocting the first time, at a simmer the front intense fire that adopts decocts, and it is rear with slow fire boiling 20～30 minutes to boil; When decocting for the second time, add water and do not have about 6 centimetres of powder, the water rear decoction 15～20 minutes of boiling.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to observe 80 cases, male 48 examples, women 32 examples, 24～80 years old age, the course of disease 2～10 years, simple atrophy gastritis 65 examples wherein, atrophic gastritis accompanied intestinal epithelial metaplasia 15 examples.
Two, diagnosis basis:
(1), gastral cavilty section pain, often accompany the diseases such as the vexed or distension of painful abdominal mass, belch, pantothenic acid, noisy, nausea and vomiting;
(2), morbidity normal with feelings will not freely, eating and drinking without temperance, fatigue, the factor such as catch cold be relevant;
(3), upper digestive tract barium meal x-ray inspection, fibergastroscope and histopathology biopsy etc. are as the auxiliary examination foundation.
Three, usage and dosage: during clinical practice, the amounts of components in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Seven days is a course for the treatment of, one day potion, the about 400ml of twice extracting juice of decocting, minute morning, late warm taking.
Four, efficacy evaluation:
(1), recovery from illness: clinical symptoms and sign disappear, and gastroscope shows that the mucosa form is recovered or basic the recovery, and the pathologic finding atrophic gastritis is changed into superficial gastritis, and intestinal epithelial metaplasia disappears;
(2), take a turn for the better: clinical symptoms and sign are clearly better, and gastroscope and pathologic finding show gastric mucosa atrophy, and inflammation, intestinal epithelial metaplasia degree alleviate;
(3), invalid: clinical symptoms and sign are without obvious improvement, and gastroscope and pathologic finding gastric mucosa are without change.
Four, therapeutic effect: in this clinical observation case, take medicine 2-20 the course for the treatment of 50 examples of fully recovering, 25 examples that take a turn for the better, invalid 5 examples.Toxic and side effects does not occur during the treatment.
Five, model case:
Case 1:
Rectify certain, woman, 56 years old.Gastralgia accompanies heartburn, belch, acid regurgitation, happiness temperature aversion to cold, constipation to have more than half a year, is diagnosed as chronic atrophic gastritis through gastroscopy, companion's intestinal epithelial metaplasia.Take 4 courses for the treatment of of medicament of Chinese medicine composition of the present invention preparation, gastralgia obviously alleviates, and is heartburn, acid regurgitation is also good, and stool can day row.Change into superficial gastritis through gastroscope check diagnosis atrophic gastritis, intestinal epithelial metaplasia disappears.
Case 2:
Zhang, woman, 60 years old.Medical private prosecution caused gastral cavilty section uncomfortable 2 years without obvious inducement, accompany noisy, mild pain, the time heartburn pantothenic acid.Be chronic atrophic gastritis through gastroscopy, companion's intestinal epithelial metaplasia.Take 5 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, the gastralgia malaise symptoms disappears, the not noisy pain of stomach, and the check gastroscope is superficial gastritis, has no intestinal.
Claims (2)
1. Chinese medicine composition for the treatment of chronic atrophic gastritis, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10～40 parts of Fructus Trichosanthis, 5～20 parts of the Rhizoma Pinelliaes, 3～15 parts of Rhizoma Coptidis, 5～25 parts of Fructus Aurantii Immaturuss, 5～20 parts in Poria, 5～25 parts of the Rhizoma Atractylodis Macrocephalaes, 5～20 parts of Fructus Toosendans, 3～15 parts of the Radix Aucklandiae, 5～25 parts of Radix Salviae Miltiorrhizaes, 3～15 parts of Fructus Amomis, 5～20 parts of Radix Angelicae Sinensis, 5～20 parts of Pollen Tyjphae, 3～10 parts in Radix Glycyrrhizae.
2. a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis according to claim 1, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 30 parts of Fructus Trichosanthis, 12 parts of the Rhizoma Pinelliaes, 6 parts of Rhizoma Coptidis, 15 parts of Fructus Aurantii Immaturuss, 10 parts in Poria, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Toosendans, 6 parts of the Radix Aucklandiae, 15 parts of Radix Salviae Miltiorrhizaes, 6 parts of Fructus Amomis, 10 parts of Radix Angelicae Sinensis, 10 parts of Pollen Tyjphae, 6 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210347287.6A CN102940839B (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating chronic atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210347287.6A CN102940839B (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating chronic atrophic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102940839A true CN102940839A (en) | 2013-02-27 |
| CN102940839B CN102940839B (en) | 2014-06-25 |
Family
ID=47723899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210347287.6A Expired - Fee Related CN102940839B (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating chronic atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940839B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520626A (en) * | 2013-10-14 | 2014-01-22 | 谭钦文 | Traditional Chinese medicine for treating liver-stomach disharmony type stuffiness and fullness |
| CN104338059A (en) * | 2014-10-24 | 2015-02-11 | 万鹏波 | Traditional Chinese medicine preparation for treating chronic atrophic gastritis |
| CN105456545A (en) * | 2016-01-25 | 2016-04-06 | 闵卫 | Medicine for treating stomach flatulence |
-
2012
- 2012-09-19 CN CN201210347287.6A patent/CN102940839B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 许文学 等: "中医治疗癌前病变专题讲座（七）", 《中国中医药现代远程教育》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520626A (en) * | 2013-10-14 | 2014-01-22 | 谭钦文 | Traditional Chinese medicine for treating liver-stomach disharmony type stuffiness and fullness |
| CN103520626B (en) * | 2013-10-14 | 2015-08-19 | 象山康丽针织厂 | The Chinese medicine for the treatment of incoordination between the liver and stomach pattern of syndrome feeling of fullness disease |
| CN104338059A (en) * | 2014-10-24 | 2015-02-11 | 万鹏波 | Traditional Chinese medicine preparation for treating chronic atrophic gastritis |
| CN105456545A (en) * | 2016-01-25 | 2016-04-06 | 闵卫 | Medicine for treating stomach flatulence |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102940839B (en) | 2014-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103550729B (en) | A kind of Chinese medicine composition for the treatment of cough | |
| CN102949630B (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN101972386A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN103272143B (en) | Traditional Chinese medicine composition for treating acne | |
| CN102641454B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN103316317A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN102940839B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis | |
| CN103330914B (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN102949553B (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN104547961B (en) | A kind of Chinese medicine composition for treating gall stone | |
| CN103006980B (en) | Chinese medicinal composition for treating distention and fullness | |
| CN103041233A (en) | Pharmaceutical composition for treating infantile diarrhea and preparation method thereof | |
| CN102940820A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN103550690B (en) | A kind of Chinese medicine composition for the treatment of superficial gastritis | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN105250858A (en) | Traditional Chinese medicine composition for treating atrophic gastritis | |
| CN104984237A (en) | Traditional Chinese medicine composition and preparation method | |
| CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN104623544A (en) | Traditional Chinese medicine preparation capable of tonifying spleen and eliminating dampness for treating moderate fatty liver and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SUN HONGXIA Free format text: FORMER OWNER: RONGCHENG YATOU MEIQUAN DENTAL CLINIC Effective date: 20140522 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sun Hongxia Inventor after: Liu Hui Inventor before: Liu Hui |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU HUI TO: SUN HONGXIA LIU HUI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140522 Address after: The middle part of Rongcheng mountain road in Weihai city Shandong province 264300 No. 298 Applicant after: Sun Hongxia Address before: 264300, No. 91, building No. 11, lotus pond North District, Weihai City, Shandong, Rongcheng Applicant before: Rongcheng Yatou Meiquan Dental Clinic |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140625 Termination date: 20140919 |
|
| EXPY | Termination of patent right or utility model |